|
US6667300B2
(en)
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
|
US8651113B2
(en)
*
|
2003-06-18 |
2014-02-18 |
Swr&D Inc. |
Magnetically responsive nanoparticle therapeutic constructs and methods of making and using
|
|
US20050054614A1
(en)
*
|
2003-08-14 |
2005-03-10 |
Diacovo Thomas G. |
Methods of inhibiting leukocyte accumulation
|
|
US20050043239A1
(en)
*
|
2003-08-14 |
2005-02-24 |
Jason Douangpanya |
Methods of inhibiting immune responses stimulated by an endogenous factor
|
|
ES2869167T3
(es)
|
2004-03-02 |
2021-10-25 |
Univ Johns Hopkins |
Mutaciones del gen PIK3CA en cánceres humanos
|
|
ES2607804T3
(es)
|
2004-05-13 |
2017-04-04 |
Icos Corporation |
Quinazolinones como inhibidores de la fosfatidilinositol humana 3-quinasa delta
|
|
JP2008500338A
(ja)
*
|
2004-05-25 |
2008-01-10 |
イコス・コーポレイション |
造血細胞の異常増殖を治療及び／又は予防する方法
|
|
EP1885356A2
(en)
*
|
2005-02-17 |
2008-02-13 |
Icos Corporation |
Phosphoinositide 3-kinase inhibitors for inhibiting leukocyte accumulation
|
|
EP1940386A4
(en)
*
|
2005-09-01 |
2010-06-23 |
Beth Israel Hospital |
WORDMAN'S CONJUGATES AND USES THEREOF
|
|
WO2007035395A2
(en)
*
|
2005-09-16 |
2007-03-29 |
Virginia Commonwealth University Intellectual Property Foundation |
Therapeutic compositions comprising chorionic gonadotropins and hmg coa reductase inhibitors
|
|
US20100003287A1
(en)
*
|
2005-12-01 |
2010-01-07 |
The Provost, Fellows And Scholars Of The Coll. Of The Holy And Undivided Trinity Of Queen Elizabeth |
Compositions and Methods Relating to Treatment of Cancer and Infectious Diseases
|
|
CA2640013A1
(en)
*
|
2006-02-09 |
2007-08-16 |
Enzon Pharmaceuticals, Inc. |
Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers
|
|
US8329683B2
(en)
*
|
2006-06-02 |
2012-12-11 |
Nexgenix Pharmaceuticals, Llc |
Treatment of neurofibromatosis with radicicol and its derivatives
|
|
WO2007143630A2
(en)
*
|
2006-06-02 |
2007-12-13 |
Nexgenix Pharmaceuticals |
Treatment of neurofibromatosis with hsp90 inhibitors
|
|
PE20090717A1
(es)
*
|
2007-05-18 |
2009-07-18 |
Smithkline Beecham Corp |
Derivados de quinolina como inhibidores de la pi3 quinasa
|
|
EP2231152B1
(en)
|
2008-01-24 |
2014-01-01 |
SignalRX Pharmaceuticals, Inc. |
Thienopyranones as kinase inhibitors
|
|
WO2009108704A1
(en)
*
|
2008-02-25 |
2009-09-03 |
Semafore Pharmaceuticals, Inc. |
O-alkylated pi-3 kinase inhibitor prodrug combination
|
|
DE102008001855A1
(de)
*
|
2008-05-19 |
2009-11-26 |
Evonik Degussa Gmbh |
Zweikomponenten-Zusammensetzung zur Herstellung von flexiblen Polyurethan-Gelcoats
|
|
US8658149B2
(en)
|
2008-05-22 |
2014-02-25 |
Ramot At Tel-Aviv University Ltd. |
Conjugates of a polymer, a bisphosphonate and an anti-angiogenesis agent and uses thereof in the treatment and monitoring of bone related diseases
|
|
WO2010019511A2
(en)
|
2008-08-13 |
2010-02-18 |
Targanta Therapeutics Corp. |
Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
|
|
CN102271683B
(zh)
|
2008-11-13 |
2014-07-09 |
吉里德卡利斯托加公司 |
恶性血液病的治疗
|
|
US9492449B2
(en)
|
2008-11-13 |
2016-11-15 |
Gilead Calistoga Llc |
Therapies for hematologic malignancies
|
|
WO2010107632A1
(en)
|
2009-03-17 |
2010-09-23 |
Woodway Usa, Inc. |
Power generating manually operated treadmill
|
|
AU2010229968A1
(en)
|
2009-03-24 |
2011-10-13 |
Gilead Calistoga Llc |
Atropisomers of2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
|
|
EP2421536B1
(en)
|
2009-04-20 |
2015-08-26 |
Gilead Calistoga LLC |
Methods of treatment for solid tumors
|
|
WO2010151711A1
(en)
|
2009-06-25 |
2010-12-29 |
Alkermes, Inc. |
Prodrugs of nh-acidic compounds
|
|
HRP20171415T4
(hr)
|
2009-06-25 |
2023-03-03 |
Alkermes Pharma Ireland Limited |
Heterociklični spojevi za liječenje neuroloških i psiholoških poremećaja
|
|
US8691829B2
(en)
|
2009-07-21 |
2014-04-08 |
Gilead Calistoga Llc |
Treatment of liver disorders with PI3K inhibitors
|
|
US8314934B2
(en)
|
2009-09-01 |
2012-11-20 |
Alltech Associates, Inc. |
Methods and apparatus for analyzing samples and collecting sample fractions
|
|
JP5889795B2
(ja)
*
|
2009-11-05 |
2016-03-22 |
ライゼン・ファーマシューティカルズ・エスアー |
新規キナーゼモジュレーター
|
|
WO2011163594A2
(en)
|
2010-06-24 |
2011-12-29 |
Alkermes, Inc. |
Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
|
|
AU2011346763B2
(en)
|
2010-12-20 |
2016-01-07 |
Glenmark Pharmaceuticals S.A. |
2-amino-4-arylthiazole compounds as TRPA1 antagonists
|
|
PL3156056T3
(pl)
|
2011-03-18 |
2024-04-29 |
Alkermes Pharma Ireland Limited |
Kompozycje farmaceutyczne zawierające estry sorbitanu
|
|
EP2693876B1
(en)
*
|
2011-04-08 |
2020-01-15 |
Sphaera Pharma Pte. Ltd |
Substituted methylformyl reagents and method of using same to modify physicochemical and/or pharmacokinetic properties of compounds
|
|
BR112014004544A2
(pt)
*
|
2011-08-31 |
2017-04-04 |
Mallinckrodt Llc |
modificação com peg de nanopartículas com h-fosfonatos
|
|
NZ722096A
(en)
|
2011-12-15 |
2016-11-25 |
Alkermes Pharma Ireland Ltd |
Prodrugs of secondary amine compounds
|
|
BRPI1107182B1
(pt)
*
|
2011-12-29 |
2022-03-08 |
Fundação De Amparo À Pesquisa Do Estado De Minas Gerais - Fapemig |
Composições farmacêuticas contendo ang-(1-7) ou outro agonista do receptor mas em combinação com inibidores de pi3k/akt para tratamento terapêutico anticâncer
|
|
WO2013134288A1
(en)
|
2012-03-05 |
2013-09-12 |
Gilead Calistoga Llc |
Polymorphic forms of (s)-2-(1-(9h-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3h)-one
|
|
EP2822598A4
(en)
|
2012-03-05 |
2016-04-13 |
Univ Ramot |
POLYMERS HAVING THERAPEUTICALLY ACTIVE AGENTS CONJUGATED THERETO, METHODS FOR THE PREPARATION OF SAID POLYMERS AND USES THEREOF
|
|
NZ630703A
(en)
|
2012-03-19 |
2017-02-24 |
Alkermes Pharma Ireland Ltd |
Pharmaceutical compositions comprising glycerol esters
|
|
JP6471089B2
(ja)
|
2012-03-19 |
2019-02-13 |
アルカームス ファーマ アイルランド リミテッド |
脂肪酸エステルを含む医薬組成物
|
|
JP6333802B2
(ja)
|
2012-03-19 |
2018-05-30 |
アルカームス ファーマ アイルランド リミテッド |
ベンジルアルコールを含む医薬組成物
|
|
AU2013349388B2
(en)
|
2012-09-19 |
2018-06-28 |
Alkermes Pharma Ireland Limited |
Pharmaceutical compositions having improved storage stability
|
|
WO2014068070A1
(en)
|
2012-10-31 |
2014-05-08 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for preventing antiphospholipid syndrome (aps)
|
|
MX2015011899A
(es)
|
2013-03-15 |
2016-05-05 |
Genentech Inc |
Metodos para el tratamiento de cáncer y prevención de resistencia a los fármacos para el cáncer.
|
|
US10072018B2
(en)
|
2013-04-17 |
2018-09-11 |
Biopharma Works |
Compounds for treatment of pain
|
|
US9487531B2
(en)
|
2013-04-17 |
2016-11-08 |
BioPharma Works LLC |
Compounds for treatment of pain
|
|
JP2017500319A
(ja)
|
2013-12-20 |
2017-01-05 |
ギリアード カリストガ エルエルシー |
（ｓ）−２−（１−（９ｈ−プリン−６−イルアミノ）プロピル）−５−フルオロ−３−フェニルキナゾリン−４（３ｈ）−オンの塩酸塩の多形形態
|
|
CN105849108A
(zh)
|
2013-12-20 |
2016-08-10 |
吉利德卡利斯托加公司 |
磷脂酰肌醇3-激酶抑制剂的制备方法
|
|
ES2921874T3
(es)
|
2014-02-28 |
2022-09-01 |
Nimbus Lakshmi Inc |
Inhibidores de TYK2 y usos de los mismos
|
|
WO2015140257A1
(en)
|
2014-03-19 |
2015-09-24 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
A method for inducing human cholangiocyte differentiation
|
|
RU2688233C2
(ru)
|
2014-03-20 |
2019-05-21 |
Алкермес Фарма Айэленд Лимитед |
Препараты арипипразола, имеющие повышенные скорости впрыска
|
|
MX2016016530A
(es)
|
2014-06-13 |
2017-03-27 |
Gilead Sciences Inc |
Inhibidores de fosfatidilinositol 3-quinasa.
|
|
EP4578865A3
(en)
|
2014-08-12 |
2025-07-30 |
Monash University |
Lymph directing prodrugs
|
|
US10736974B2
(en)
*
|
2014-10-22 |
2020-08-11 |
The Johns Hopkins University |
Scaffolds and multifunctional intermediates for imaging PSMA and cancer therapy
|
|
CA3220466A1
(en)
|
2014-10-29 |
2016-05-06 |
Bicyclerd Limited |
Bicyclic peptide ligands specific for mt1-mmp
|
|
ES2930585T3
(es)
|
2015-02-27 |
2022-12-19 |
Nimbus Lakshmi Inc |
Inhibidores de TYK2 y usos de los mismos
|
|
WO2017004134A1
(en)
|
2015-06-29 |
2017-01-05 |
Nimbus Iris, Inc. |
Irak inhibitors and uses thereof
|
|
US10253052B2
(en)
|
2015-07-07 |
2019-04-09 |
Five Eleven Pharma Inc. |
HBED-bisphosphonates, radiometal conjugates and their use as theranostic agents
|
|
US10023571B2
(en)
|
2015-09-02 |
2018-07-17 |
Nimbus Lakshimi, Inc. |
TYK2 inhibitors and uses thereof
|
|
CN108137482B
(zh)
|
2015-09-08 |
2024-03-15 |
莫纳什大学 |
定向淋巴的前药
|
|
WO2017044720A1
(en)
|
2015-09-11 |
2017-03-16 |
Navitor Pharmaceuticals, Inc. |
Rapamycin analogs and uses thereof
|
|
WO2017062504A1
(en)
|
2015-10-06 |
2017-04-13 |
Woodway Usa, Inc. |
Manual treadmill and methods of operating the same
|
|
SI3364958T1
(sl)
|
2015-10-23 |
2023-05-31 |
Navitor Pharmaceuticals, Inc. |
Modulatorji interakcije sestrina in gator2 ter njihova uporaba
|
|
TWI729028B
(zh)
*
|
2015-11-17 |
2021-06-01 |
日商日產化學工業股份有限公司 |
寡核苷酸的製造方法
|
|
WO2017106352A1
(en)
|
2015-12-14 |
2017-06-22 |
Raze Therapeutics, Inc. |
Caffeine inhibitors of mthfd2 and uses thereof
|
|
EP4234552A3
(en)
|
2016-03-09 |
2023-10-18 |
Raze Therapeutics, Inc. |
3-phosphoglycerate dehydrogenase inhibitors and uses thereof
|
|
PL3426243T3
(pl)
|
2016-03-09 |
2021-10-04 |
Raze Therapeutics, Inc. |
Inhibitory dehydrogenazy 3-fosfoglicerynianowej i ich zastosowania
|
|
WO2017162536A1
(en)
|
2016-03-21 |
2017-09-28 |
H. Lundbeck A/S |
Vortioxetine prodrugs
|
|
WO2017175022A1
(en)
|
2016-04-07 |
2017-10-12 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for inhibiting mast cell degranulation
|
|
WO2017177230A1
(en)
|
2016-04-08 |
2017-10-12 |
X4 Pharmaceuticals, Inc. |
Methods for treating cancer
|
|
CN109640988A
(zh)
|
2016-06-21 |
2019-04-16 |
X4 制药有限公司 |
Cxcr4抑制剂及其用途
|
|
EP3808748A1
(en)
|
2016-06-21 |
2021-04-21 |
X4 Pharmaceuticals, Inc. |
Substituted piperidines as cxcr4-inhibitors
|
|
CA3027500A1
(en)
|
2016-06-21 |
2017-12-28 |
X4 Pharmaceuticals, Inc. |
Cxcr4 inhibitors and uses thereof
|
|
EP3906979A1
(en)
|
2016-07-01 |
2021-11-10 |
Woodway USA, Inc. |
Motorized treadmill with motor braking mechanism and methods of operating same
|
|
US10072032B2
(en)
*
|
2016-09-19 |
2018-09-11 |
Afton Chemical Corporation |
AminoBisPhosphonate antiwear additives
|
|
TWI825663B
(zh)
|
2016-10-14 |
2023-12-11 |
美商林伯士拉克許米公司 |
Tyk2抑制劑及其用途
|
|
EP3528816A4
(en)
|
2016-10-21 |
2020-04-08 |
Nimbus Lakshmi, Inc. |
TYK2 INHIBITORS AND USES THEREOF
|
|
WO2018089499A1
(en)
|
2016-11-08 |
2018-05-17 |
Navitor Pharmaceuticals, Inc. |
PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF
|
|
JP2019535839A
(ja)
|
2016-11-29 |
2019-12-12 |
ピュアテック ヘルス エルエルシー |
治療剤の送達のためのエクソソーム
|
|
WO2018106636A1
(en)
|
2016-12-05 |
2018-06-14 |
Raze Therapeutics, Inc. |
Shmt inhibitors and uses thereof
|
|
US11730819B2
(en)
|
2016-12-23 |
2023-08-22 |
Bicycletx Limited |
Peptide derivatives having novel linkage structures
|
|
EP3565638B8
(en)
|
2017-01-06 |
2024-04-10 |
BicycleRD Limited |
Bicycle conjugate for treating cancer
|
|
WO2018140730A1
(en)
|
2017-01-27 |
2018-08-02 |
Signalrx Pharmaceuticals, Inc. |
Thienopyranones and furanopyranones as kinase, bromodomain, and checkpoint inhibitors
|
|
US10336752B2
(en)
|
2017-03-08 |
2019-07-02 |
Nimbus Lakshmi, Inc. |
TYK2 inhibitors, uses, and methods for production thereof
|
|
EP3375784A1
(en)
|
2017-03-14 |
2018-09-19 |
Artax Biopharma Inc. |
Aza-dihydro-acridone derivatives
|
|
EP3375778A1
(en)
|
2017-03-14 |
2018-09-19 |
Artax Biopharma Inc. |
Aryl-piperidine derivatives
|
|
WO2018191146A1
(en)
|
2017-04-10 |
2018-10-18 |
Navitor Pharmaceuticals, Inc. |
Heteroaryl rheb inhibitors and uses thereof
|
|
JPWO2018199174A1
(ja)
*
|
2017-04-25 |
2020-02-27 |
生化学工業株式会社 |
第３級アミン化合物又はイミン化合物−ポリマーコンジュゲートとその製造方法
|
|
WO2018200625A1
(en)
|
2017-04-26 |
2018-11-01 |
Navitor Pharmaceuticals, Inc. |
Modulators of sestrin-gator2 interaction and uses thereof
|
|
EP3615550A1
(en)
|
2017-04-27 |
2020-03-04 |
BicycleTx Limited |
Bicyclic peptide ligands and uses thereof
|
|
EP3619196B1
(de)
|
2017-05-04 |
2022-03-30 |
Bayer CropScience Aktiengesellschaft |
2-{[2-(phenyloxymethyl)pyridin-5-yl]oxy}-ethanamin-derivate und verwandte verbindungen als schädlingsbekämpfungsmittel z.b. für den pflanzenschutz
|
|
CN108929329B
(zh)
*
|
2017-05-24 |
2020-12-11 |
中国医学科学院药物研究所 |
2-氮杂环-5-三氟甲基-8-硝基苯并(硫代)吡喃-4-酮类化合物
|
|
EP3645549A1
(en)
|
2017-06-26 |
2020-05-06 |
BicycleRD Limited |
Bicyclic peptide ligands with detectable moieties and uses thereof
|
|
MY205416A
(en)
|
2017-07-28 |
2024-10-21 |
Takeda Pharmaceuticals Co |
Tyk2 inhibitors and uses thereof
|
|
US11261214B2
(en)
|
2017-08-04 |
2022-03-01 |
Bicycletx Limited |
Bicyclic peptide ligand specific for CD137
|
|
US20200291096A1
(en)
|
2017-08-14 |
2020-09-17 |
Bicyclerd Limited |
Bicyclic peptide ligand sting conjugates and uses thereof
|
|
EP3668550A1
(en)
|
2017-08-14 |
2020-06-24 |
Bicyclerd Limited |
Bicyclic peptide ligand prr-a conjugates and uses thereof
|
|
EP4306524A3
(en)
|
2017-08-29 |
2024-09-11 |
PureTech LYT, Inc. |
Lymphatic system-directing lipid prodrugs
|
|
US11883497B2
(en)
|
2017-08-29 |
2024-01-30 |
Puretech Lyt, Inc. |
Lymphatic system-directing lipid prodrugs
|
|
EP3684366A4
(en)
|
2017-09-22 |
2021-09-08 |
Kymera Therapeutics, Inc. |
CRBN LIGANDS AND USES OF THE LATEST
|
|
EP3684365A4
(en)
|
2017-09-22 |
2021-09-08 |
Kymera Therapeutics, Inc. |
PROTEIN DEGRADATION AGENTS AND USES OF SUCH
|
|
EP3727362A4
(en)
|
2017-12-19 |
2021-10-06 |
PureTech LYT, Inc. |
MYCOPHENOLIC ACID LIPID MEDICINAL PRODUCTS AND THEIR USES
|
|
TWI825046B
(zh)
|
2017-12-19 |
2023-12-11 |
英商拜西可泰克斯有限公司 |
Epha2特用之雙環胜肽配位基
|
|
US11608345B1
(en)
|
2017-12-19 |
2023-03-21 |
Puretech Lyt, Inc. |
Lipid prodrugs of rapamycin and its analogs and uses thereof
|
|
GB201721265D0
(en)
|
2017-12-19 |
2018-01-31 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for EphA2
|
|
US11304954B2
(en)
|
2017-12-19 |
2022-04-19 |
Puretech Lyt, Inc. |
Lipid prodrugs of mycophenolic acid and uses thereof
|
|
CN108003188A
(zh)
*
|
2017-12-25 |
2018-05-08 |
长春吉大天元化学技术股份有限公司 |
一种烷基磷酸酯类化合物的新型纯化方法
|
|
IL315310A
(en)
|
2017-12-26 |
2024-10-01 |
Kymera Therapeutics Inc |
Irak degraders and uses thereof
|
|
EP3737666A4
(en)
|
2018-01-12 |
2022-01-05 |
Kymera Therapeutics, Inc. |
PROTEIN DEGRADATION AGENTS AND ASSOCIATED USES
|
|
EP3737675A4
(en)
|
2018-01-12 |
2022-01-05 |
Kymera Therapeutics, Inc. |
Crbn ligands and uses thereof
|
|
US10793563B2
(en)
|
2018-01-29 |
2020-10-06 |
Merck Patent Gmbh |
GCN2 inhibitors and uses thereof
|
|
KR20200116481A
(ko)
|
2018-01-29 |
2020-10-12 |
메르크 파텐트 게엠베하 |
Gcn2 억제제 및 이의 용도
|
|
WO2019157516A1
(en)
|
2018-02-12 |
2019-08-15 |
resTORbio, Inc. |
Combination therapies
|
|
MX2020008791A
(es)
|
2018-02-23 |
2021-01-08 |
Bicycletx Ltd |
Ligandos de peptidos biciclicos multimericos.
|
|
CN117304157A
(zh)
|
2018-02-27 |
2023-12-29 |
阿塔克斯生物制药有限公司 |
作为tcr-nck相互作用的抑制剂的色烯衍生物
|
|
AU2019230014B2
(en)
|
2018-03-05 |
2024-11-28 |
Alkermes Pharma Ireland Limited |
Aripiprazole dosing strategy
|
|
ES2969982T3
(es)
|
2018-04-24 |
2024-05-23 |
Vertex Pharma |
Compuestos de pteridinona y usos de los mismos
|
|
IL301501B2
(en)
|
2018-04-24 |
2024-10-01 |
Vertex Pharma |
Antiproliferation compounds and uses thereof
|
|
EA202092692A1
(ru)
|
2018-06-15 |
2021-04-21 |
Навитор Фармасьютикалз, Инк. |
Аналоги рапамицина и их применения
|
|
IL279489B2
(en)
|
2018-06-22 |
2025-10-01 |
Bicycletx Ltd |
Bicyclic peptide ligands specific for nectin-4, a drug conjugate containing the peptide ligands and a pharmaceutical composition containing the drug conjugate
|
|
GB201810316D0
(en)
|
2018-06-22 |
2018-08-08 |
Bicyclerd Ltd |
Peptide ligands for binding to EphA2
|
|
EP3817822A4
(en)
|
2018-07-06 |
2022-07-27 |
Kymera Therapeutics, Inc. |
PROTEIN DEGRADANTS AND USES THEREOF
|
|
WO2020010177A1
(en)
|
2018-07-06 |
2020-01-09 |
Kymera Therapeutics, Inc. |
Tricyclic crbn ligands and uses thereof
|
|
WO2020023340A1
(en)
|
2018-07-23 |
2020-01-30 |
Signalrx Pharmaceuticals, Inc. |
Single molecule compounds providing multi-target inhibition of btk and other proteins and methods of use thereof
|
|
US10548889B1
(en)
|
2018-08-31 |
2020-02-04 |
X4 Pharmaceuticals, Inc. |
Compositions of CXCR4 inhibitors and methods of preparation and use
|
|
JPWO2020050378A1
(ja)
*
|
2018-09-06 |
2021-08-30 |
生化学工業株式会社 |
第３級アミン化合物又はイミン化合物を結合させた、ポリマーコンジュゲートとその製造方法
|
|
EP3846793B1
(en)
|
2018-09-07 |
2024-01-24 |
PIC Therapeutics, Inc. |
Eif4e inhibitors and uses thereof
|
|
CN113271940A
(zh)
|
2018-10-15 |
2021-08-17 |
林伯士拉克许米公司 |
Tyk2抑制剂和其用途
|
|
WO2020084305A1
(en)
|
2018-10-23 |
2020-04-30 |
Bicycletx Limited |
Bicyclic peptide ligands and uses thereof
|
|
EP3870158A4
(en)
|
2018-10-24 |
2022-08-10 |
Navitor Pharmaceuticals, Inc. |
Polymorphic compounds and uses thereof
|
|
SG11202105424PA
(en)
|
2018-11-30 |
2021-06-29 |
Kymera Therapeutics Inc |
Irak degraders and uses thereof
|
|
CN113271938A
(zh)
|
2018-11-30 |
2021-08-17 |
林伯士拉克许米公司 |
Tyk2抑制剂和其用途
|
|
GB201820325D0
(en)
|
2018-12-13 |
2019-01-30 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for psma
|
|
GB201820288D0
(en)
|
2018-12-13 |
2019-01-30 |
Bicycle Tx Ltd |
Bicycle peptide ligaands specific for MT1-MMP
|
|
EP3670659A1
(en)
|
2018-12-20 |
2020-06-24 |
Abivax |
Biomarkers, and uses in treatment of viral infections, inflammations, or cancer
|
|
WO2020154474A1
(en)
|
2019-01-23 |
2020-07-30 |
Nimbus Lakshmi, Inc. |
Tyk2 inhibitors and uses thereof
|
|
WO2020165600A1
(en)
|
2019-02-14 |
2020-08-20 |
Bicycletx Limited |
Bicyclic peptide ligand sting conjugates and uses thereof
|
|
USD930089S1
(en)
|
2019-03-12 |
2021-09-07 |
Woodway Usa, Inc. |
Treadmill
|
|
US20220184222A1
(en)
|
2019-04-02 |
2022-06-16 |
Bicycletx Limited |
Bicycle toxin conjugates and uses thereof
|
|
SG11202110829YA
(en)
|
2019-04-05 |
2021-10-28 |
Kymera Therapeutics Inc |
Stat degraders and uses thereof
|
|
TW202108559A
(zh)
|
2019-05-31 |
2021-03-01 |
美商醫肯納腫瘤學公司 |
Tead抑制劑及其用途
|
|
TWI860386B
(zh)
|
2019-07-30 |
2024-11-01 |
英商拜西可泰克斯有限公司 |
異質雙環肽複合物
|
|
AU2020345962A1
(en)
|
2019-09-11 |
2022-03-31 |
Vincere Biosciences, Inc. |
USP30 inhibitors and uses thereof
|
|
EP4027995A4
(en)
|
2019-09-13 |
2023-08-23 |
Nimbus Saturn, Inc. |
HPK1 ANTAGONISTS AND THEIR APPLICATIONS
|
|
TWI870497B
(zh)
|
2019-11-01 |
2025-01-21 |
美商奈維特製藥公司 |
使用mtorc1調節劑的治療方法
|
|
AU2020397938A1
(en)
|
2019-12-05 |
2022-06-23 |
Janssen Pharmaceutica Nv |
Rapamycin analogs and uses thereof
|
|
EP4076524A4
(en)
|
2019-12-17 |
2023-11-29 |
Kymera Therapeutics, Inc. |
IRAQ DEGRADERS AND USES THEREOF
|
|
MX2022007576A
(es)
|
2019-12-17 |
2022-09-23 |
Kymera Therapeutics Inc |
Degradadores de cinasas asociadas al receptor de interleucina-1 (irak) y usos de los mismos.
|
|
IL294150A
(en)
|
2019-12-23 |
2022-08-01 |
Kymera Therapeutics Inc |
Smarca joints and their uses
|
|
JP2023514147A
(ja)
|
2020-02-05 |
2023-04-05 |
ピュアテック・エル・ワイ・ティ・インコーポレイテッド |
神経ステロイドの脂質プロドラッグ
|
|
AU2021230289A1
(en)
|
2020-03-03 |
2022-09-29 |
PIC Therapeutics, Inc. |
eIF4E inhibitors and uses thereof
|
|
MX2022011602A
(es)
|
2020-03-19 |
2023-01-04 |
Kymera Therapeutics Inc |
Degradadores de la proteína de homólogo de ratón de minuto 2 (mdm2) y usos de los mismos.
|
|
EP4161521A4
(en)
|
2020-06-03 |
2024-07-10 |
Kymera Therapeutics, Inc. |
DEUTERED IRAQ DEGRADERS AND USES THEREOF
|
|
TW202210483A
(zh)
|
2020-06-03 |
2022-03-16 |
美商凱麥拉醫療公司 |
Irak降解劑之結晶型
|
|
EP4196792A1
(en)
|
2020-08-17 |
2023-06-21 |
BicycleTX Limited |
Bicycle conjugates specific for nectin-4 and uses thereof
|
|
EP4232425A4
(en)
|
2020-10-23 |
2024-07-24 |
Nimbus Clotho, Inc. |
Ctps1 inhibitors and uses thereof
|
|
CA3200814A1
(en)
|
2020-12-02 |
2022-06-09 |
Alfredo C. Castro |
Tead inhibitors and uses thereof
|
|
WO2022120353A1
(en)
|
2020-12-02 |
2022-06-09 |
Ikena Oncology, Inc. |
Tead inhibitors and uses thereof
|
|
AU2021413371A1
(en)
|
2020-12-30 |
2023-07-13 |
Kymera Therapeutics, Inc. |
Irak degraders and uses thereof
|
|
CN117098757A
(zh)
|
2021-02-02 |
2023-11-21 |
里米诺生物科学有限公司 |
Gpr84拮抗剂和其用途
|
|
AU2022215844A1
(en)
|
2021-02-02 |
2023-09-14 |
Liminal Biosciences Limited |
Gpr84 antagonists and uses thereof
|
|
CN117120090A
(zh)
|
2021-02-12 |
2023-11-24 |
林伯士萨顿公司 |
Hpk1拮抗剂和其用途
|
|
AU2022220043A1
(en)
|
2021-02-15 |
2023-08-31 |
Kymera Therapeutics, Inc. |
Irak4 degraders and uses thereof
|
|
AU2022220869A1
(en)
|
2021-02-15 |
2023-08-24 |
Kymera Therapeutics, Inc. |
Irak4 degraders and uses thereof
|
|
US11926625B2
(en)
|
2021-03-05 |
2024-03-12 |
Nimbus Saturn, Inc. |
HPK1 antagonists and uses thereof
|
|
EP4313989A4
(en)
|
2021-03-29 |
2025-03-05 |
Nimbus Saturn, Inc. |
HPK1 ANTAGONISTS AND USES THEREOF
|
|
EP4319756A4
(en)
|
2021-04-09 |
2025-02-26 |
Nimbus Clio, Inc. |
CBL-B MODULATORS AND USES THEREOF
|
|
JP2024514879A
(ja)
|
2021-04-16 |
2024-04-03 |
イケナ オンコロジー， インコーポレイテッド |
Ｍｅｋ阻害剤及びその使用
|
|
US12097261B2
(en)
|
2021-05-07 |
2024-09-24 |
Kymera Therapeutics, Inc. |
CDK2 degraders and uses thereof
|
|
JP2024532276A
(ja)
|
2021-08-25 |
2024-09-05 |
ピク セラピューティクス， インコーポレイテッド |
ｅＩＦ４Ｅ阻害剤及びその使用
|
|
CA3229560A1
(en)
|
2021-08-25 |
2023-03-02 |
Christopher L. Vandeusen |
Eif4e inhibitors and uses thereof
|
|
CN118302168A
(zh)
|
2021-10-29 |
2024-07-05 |
凯麦拉医疗公司 |
Irak4降解剂和其制备
|
|
WO2023114984A1
(en)
|
2021-12-17 |
2023-06-22 |
Ikena Oncology, Inc. |
Tead inhibitors and uses thereof
|
|
EP4472967A2
(en)
|
2022-01-31 |
2024-12-11 |
Kymera Therapeutics, Inc. |
Irak degraders and uses thereof
|
|
WO2023173057A1
(en)
|
2022-03-10 |
2023-09-14 |
Ikena Oncology, Inc. |
Mek inhibitors and uses thereof
|
|
WO2023173053A1
(en)
|
2022-03-10 |
2023-09-14 |
Ikena Oncology, Inc. |
Mek inhibitors and uses thereof
|
|
WO2023211889A1
(en)
|
2022-04-25 |
2023-11-02 |
Ikena Oncology, Inc. |
Polymorphic compounds and uses thereof
|
|
WO2023230205A1
(en)
|
2022-05-25 |
2023-11-30 |
Ikena Oncology, Inc. |
Mek inhibitors and uses thereof
|
|
IL318576A
(en)
|
2022-08-02 |
2025-03-01 |
Liminal Biosciences Ltd |
Pyridoxine-substituted GPR84 antagonists and their uses
|
|
KR20250057800A
(ko)
|
2022-08-02 |
2025-04-29 |
리미널 바이오사이언시스 리미티드 |
헤테로아릴 카복스아마이드 및 관련 gpr84 길항제 및 이의 용도
|
|
WO2024028364A1
(en)
|
2022-08-02 |
2024-02-08 |
Liminal Biosciences Limited |
Aryl-triazolyl and related gpr84 antagonists and uses thereof
|
|
US20240208961A1
(en)
|
2022-11-22 |
2024-06-27 |
PIC Therapeutics, Inc. |
Eif4e inhibitors and uses thereof
|
|
WO2024264017A2
(en)
|
2023-06-23 |
2024-12-26 |
Kymera Therapeutics, Inc. |
Irak degraders and uses thereof
|
|
TW202529769A
(zh)
|
2023-09-21 |
2025-08-01 |
日商武田藥品工業股份有限公司 |
Ｔｙｋ２抑制劑及其用途
|